IRCT201202048917N1CompletedPhase 1
Effect of topical finasteride on treatment of patients with androgenic alopecia
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Enrollment
- 58
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Inclusion criterion: (to have androgenic alopecia of any type)
- •Exclusion criteria: (to be pregnant; to have non-androgenic alopecia in other regions of the body; to have signs of allergy to finasteride)
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
Comparative efficacy study of topical finasteride in androgenic alopeciaIRCT20191203045592N2Esfahan University of Medical Sciences40
Recruiting
Phase 2
Safety and efficacy of topical finasteride nanoemulgel 0.25% in the treatment of mild to moderate androgenetic alopeciahair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20190210042676N22Tehran University of Medical Sciences40
Completed
Not Applicable
Topical Finasteride in the Treatment of Idiopathic HirsutismIdiopathic HirsutismNCT00564252Iran University of Medical Sciences56
Completed
Phase 1
Finasteride effect as a treatment for spontaneous retinal edemaCentral Serous Chorioretinopathy.Separation of retinal layersIRCT2013083114530N1Shahid Sadoughi University of Medical Science30
Completed
Phase 3
Effect of finasterid on COVID-19 treatmentCorona virus pneumonia.COVID-19,virus not identifiedU07.2IRCT20200505047318N1Qazvin University of Medical Sciences80